CSL (OTCMKTS:CSLLY) Rating Increased to Moderate Buy at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of CSL (OTCMKTS:CSLLY – Free Report) from a hold rating to a moderate buy rating in a research report sent to investors on Tuesday morning,Zacks reports.

Several other brokerages have also weighed in on CSLLY. Jefferies Financial Group lowered shares of CSL from a “strong-buy” rating to a “hold” rating in a report on Friday, May 29th. Zacks Research upgraded shares of CSL from a “strong sell” rating to a “hold” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Get CSL alerts:

Get Our Latest Stock Analysis on CSLLY

CSL Trading Down 3.2%

CSLLY stock opened at $30.65 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.57 and a quick ratio of 1.15. The firm has a 50 day simple moving average of $25.97 and a 200-day simple moving average of $23.34. CSL has a twelve month low of $16.01 and a twelve month high of $36.28.

About CSL

(Get Free Report)

CSL Limited (OTCMKTS:CSLLY) is an Australian biotechnology company that develops, manufactures and supplies medicines and vaccines. Founded in 1916 as the Commonwealth Serum Laboratories, the company was privatized in 1994 and has grown into a global provider of specialized biopharmaceutical products.

CSL’s principal businesses include CSL Behring, which develops plasma-derived and recombinant therapies for immune deficiencies, bleeding disorders and other serious medical conditions; CSL Seqirus, which produces influenza and other vaccines; and CSL Vifor, which focuses on therapies for iron deficiency, kidney disease and related conditions.

Featured Stories

• Five stocks we like better than CSL
• This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
• Analysts See Double-Digit Upside for These 3 Stocks
• 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
• Jackson’s Record Quarter Powers the Bull Case

Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.